Skip to content
  • About Us
    • Our Story and Mission
    • Tucker’s Message
    • Executive Committee, Management & Staff
    • Board of Directors
    • Medical and Scientific Advisors
    • Patient and Caregiver Advisors
    • Financial Information
  • News & Media
    • Announcements
    • Press Releases
  • For Researchers
Fibrolamellar Cancer Foundation
Fibrolamellar Cancer Foundation
  • About Fibro
    • What is Fibrolamellar Carcinoma?
    • Fibrolamellar FAQ’s
    • Faces of Fibrolamellar
    • A Mother’s Story
    • Newly Diagnosed
  • Treatments
    • Introduction
    • Surgery
    • Chemotherapy
    • Targeted Therapy
    • Immunotherapy
    • Interventional Radiology
    • Radiation
    • Palliative Care
  • Research
    • Research Publication Library
    • Research Overview
    • FCF Funding Priorities
    • Funded Projects
    • Total Grant Funding and Impact
  • Resources & Events
    • Connect with Other Patients
    • Events Calendar
    • Find A Doctor
    • Helpful Resources
    • Glossary of terms
  • Clinical Trials
  • Join the Fight
    • Donate Tumor Tissue
    • Become a Grant Reviewer
    • Provide Data for Research
    • Share Your Story
    • Become a FCF Ambassador
    • Volunteer
    • Get a Fibrolamellar Calendar
    • Give
  • Giving

Home » FCF

FCF

Defining incidence of fibrolamellar carcinoma through computational analysis of multiple data types

Timeframe: 2021 – 2022 Goal: Develop updated estimate for US national incidence of FLC Investigators: John Gordan, MD, PhD (UCSF); Travis Zack, MD (UCSF); and Kurt Losert (FCF) Study overview: Rare diseases like fibrolamellar are often poorly understood because of the difficulty in assembling accurate patient cohorts and the lack of ICD billing codes specific …

Read more

Get In Touch
map marker
20 Horseneck Lane
2nd Floor
Greenwich, CT 06830
phone
(203) 340-7800
mail
info@fibrofoundation.org

facebook twitter instagram youtube
Recent Announcements
  • Giving Tuesday 2023November 27, 2023
  • FCF funds new multi-institution collaborationNovember 13, 2023
  • New clinical trial open in GermanyOctober 12, 2023
About FCF

This site does not provide medical advice, diagnosis, or treatment. FCF is a 501 (c) (3) tax exempt public charity.

Charity Navigator Give With Confidence      

  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
  • Donor Privacy Policy
  • Gift Acceptance Policy
2023 © Fibrolamellar Cancer Foundation